Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Therapanacea Sas

US

Last updated May 23, 2026

What Therapanacea Sas makes

Therapanacea Sas develops software for radiation therapy planning, including versions of ART-Plan and ART-Plan+ (across multiple iterations). These tools assist in treatment planning and dose calculations for radiotherapy procedures.

The company’s products are classified as Class II devices under FDA regulations and are listed in the FDA’s 510(k) and UDI registries. Therapanacea Sas operates from the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (8)

DeviceModel / ReferenceRegistriesClassStatus
ART-Plan v.1.10.0
FDA UDI
Class IIActive
ART-Plan K232479
FDA 510(k)
Class IIActive
ART-Plan+ (v3.1.0) K253091
FDA 510(k)
Class IIActive
Art-Plan K220813
FDA 510(k)
Class IIActive
ART-Plan K202700
FDA 510(k)
Class IIActive
ART-Plan K230023
FDA 510(k)
Class IIActive
ART-Plan+ (v.3.0.0) K242822
FDA 510(k)
Class IIActive
ART-Plan (v.2.2.0) K234068
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Establishments (1)

Establishments registered with the FDA under this company group, matched by name.

  • Therapanacea Paris · FR FEI 3019834893